EcoR1 Capital’s Poseida Therapeutics PSTX Stock Holding History
Bought
Maintained
Sold
Other funds holding PSTX
EcoR1 Capital's PSTX Position: Q3 2023 in Review
EcoR1 Capital sold out of Poseida Therapeutics (PSTX) in Q3 2023, closing a stake of 676,296 shares — an estimated $1.19M sold.
EcoR1 Capital first reported a position in PSTX in Q3 2022 and held it in 4 quarters. The position peaked at $14M in Q4 2022. 86 funds tracked by Wall St. Rank hold PSTX as of Q3 2023.
- EcoR1 Capital reported no remaining Poseida Therapeutics position as of Q3 2023 after selling out during the quarter.
- EcoR1 Capital sold 676,296 Poseida Therapeutics shares in Q3 2023, an estimated $1.19M.
- EcoR1 Capital first reported a position in Poseida Therapeutics in Q3 2022 and held it in 4 quarters.
- EcoR1 Capital's Poseida Therapeutics position peaked at $14M in Q4 2022.
- 86 funds tracked by Wall St. Rank held Poseida Therapeutics as of Q3 2023.
Based on EcoR1 Capital's 13F filing for Q3 2023, filed 14 Nov 2023.